The Experts below are selected from a list of 24 Experts worldwide ranked by ideXlab platform
W Tilgen - One of the best experts on this subject based on the ideXlab platform.
-
treatment of Progressive Pigmented Purpura with oral bioflavonoids and ascorbic acid an open pilot study in 3 patients
Journal of The American Academy of Dermatology, 1999Co-Authors: U Reinhold, S Seiter, S Ugurel, W TilgenAbstract:Abstract Background: Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. Objective: We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic Progressive Pigmented Purpura (PPP). Methods: In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. Results: At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Conclusion: Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP. Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP. (J Am Acad Dermatol 1999;41:207-8.)
-
Treatment of Progressive Pigmented Purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients.
Journal of the American Academy of Dermatology, 1999Co-Authors: U Reinhold, S Seiter, S Ugurel, W TilgenAbstract:Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic Progressive Pigmented Purpura (PPP). In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP. Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP.
U Reinhold - One of the best experts on this subject based on the ideXlab platform.
-
treatment of Progressive Pigmented Purpura with oral bioflavonoids and ascorbic acid an open pilot study in 3 patients
Journal of The American Academy of Dermatology, 1999Co-Authors: U Reinhold, S Seiter, S Ugurel, W TilgenAbstract:Abstract Background: Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. Objective: We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic Progressive Pigmented Purpura (PPP). Methods: In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. Results: At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Conclusion: Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP. Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP. (J Am Acad Dermatol 1999;41:207-8.)
-
Treatment of Progressive Pigmented Purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients.
Journal of the American Academy of Dermatology, 1999Co-Authors: U Reinhold, S Seiter, S Ugurel, W TilgenAbstract:Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic Progressive Pigmented Purpura (PPP). In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP. Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP.
S Seiter - One of the best experts on this subject based on the ideXlab platform.
-
treatment of Progressive Pigmented Purpura with oral bioflavonoids and ascorbic acid an open pilot study in 3 patients
Journal of The American Academy of Dermatology, 1999Co-Authors: U Reinhold, S Seiter, S Ugurel, W TilgenAbstract:Abstract Background: Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. Objective: We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic Progressive Pigmented Purpura (PPP). Methods: In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. Results: At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Conclusion: Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP. Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP. (J Am Acad Dermatol 1999;41:207-8.)
-
Treatment of Progressive Pigmented Purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients.
Journal of the American Academy of Dermatology, 1999Co-Authors: U Reinhold, S Seiter, S Ugurel, W TilgenAbstract:Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic Progressive Pigmented Purpura (PPP). In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP. Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP.
S Ugurel - One of the best experts on this subject based on the ideXlab platform.
-
treatment of Progressive Pigmented Purpura with oral bioflavonoids and ascorbic acid an open pilot study in 3 patients
Journal of The American Academy of Dermatology, 1999Co-Authors: U Reinhold, S Seiter, S Ugurel, W TilgenAbstract:Abstract Background: Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. Objective: We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic Progressive Pigmented Purpura (PPP). Methods: In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. Results: At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Conclusion: Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP. Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP. (J Am Acad Dermatol 1999;41:207-8.)
-
Treatment of Progressive Pigmented Purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients.
Journal of the American Academy of Dermatology, 1999Co-Authors: U Reinhold, S Seiter, S Ugurel, W TilgenAbstract:Bioflavonoids and ascorbic acid have been shown to increase capillary resistance and to mediate potent antioxidative radical scavenging activities. We evaluated the clinical effect of oral bioflavonoids and ascorbic acid in patients with chronic Progressive Pigmented Purpura (PPP). In an open pilot study, oral rutoside (50 mg twice a day) and ascorbic acid (500 mg twice a day) were administered to 3 patients with chronic PPP. At the end of the 4-week treatment period, complete clearance of the skin lesions was achieved in all 3 patients. No adverse reactions were noted. All patients remained free of lesions at the end of 3 months after treatment. Our results suggest a beneficial effect of bioflavonoids in combination with ascorbic acid on PPP. Because the disease is mostly resistant to other treatment modalities, placebo-controlled studies are necessary to determine the usefulness of this therapy in PPP.
Thomas Vogt - One of the best experts on this subject based on the ideXlab platform.
-
Zosteriform Pigmented Purpura of Schamberg: case report and differential diagnosis of zosteriform skin lesions
Journal Der Deutschen Dermatologischen Gesellschaft, 2004Co-Authors: Philipp Babilas, Alexander Roesch, Rolf-markus Szeimies, Michael Landthaler, Thomas VogtAbstract:A 13-year-old boy presented with Progressive Pigmented Purpura of Schamberg in an unusual zosteriform distribution. He recently has taken methylphenidate which has not been described as a cause of Schamberg disease. Many different skin diseases can present in a zosteriform distribution. They are reviewed systematically and sorted by pathogenetic criteria.
